NASDAQ:LXRX - Lexicon Pharmaceuticals News Headlines

$2.74
+0.40 (+17.09 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
$2.34
Now: $2.74
$2.80
50-Day Range
$1.20
MA: $1.55
$5.69
52-Week Range
$1.13
Now: $2.74
$11.51
Volume3.18 million shs
Average Volume1.09 million shs
Market Capitalization$291.19 million
P/E RatioN/A
Dividend YieldN/A
Beta0.75

Headlines

Lexicon Pharmaceuticals (NASDAQ LXRX) News Headlines

Source:
DateHeadline
FY2019 EPS Estimates for Lexicon Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:LXRX)FY2019 EPS Estimates for Lexicon Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:LXRX)
www.americanbankingnews.com - September 13 at 6:43 AM
Heres Why Lexicon Pharmaceuticals Is Soaring This WeekHere's Why Lexicon Pharmaceuticals Is Soaring This Week
www.fool.com - September 12 at 4:59 PM
Lexicon Gets Some Clarity And Cash For Its Zynquista Diabetes ProgramLexicon Gets Some Clarity And Cash For Its Zynquista Diabetes Program
seekingalpha.com - September 12 at 4:59 PM
Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded to "Buy" at G.ResearchLexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded to "Buy" at G.Research
www.americanbankingnews.com - September 12 at 7:33 AM
Lexicon Pharmaceuticals (NASDAQ:LXRX) Lifted to "Buy" at GabelliLexicon Pharmaceuticals (NASDAQ:LXRX) Lifted to "Buy" at Gabelli
www.americanbankingnews.com - September 11 at 10:13 AM
Sanofi pays Lexicon $260M on termination of Zynquista collaborationSanofi pays Lexicon $260M on termination of Zynquista collaboration
seekingalpha.com - September 11 at 6:55 AM
Market Sentiment Around Loss-Making Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)Market Sentiment Around Loss-Making Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)
finance.yahoo.com - September 11 at 6:55 AM
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With SanofiLexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi
finance.yahoo.com - September 11 at 6:55 AM
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual MeetingLexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting
finance.yahoo.com - September 11 at 6:55 AM
Sanofi to pay Lexicon $260 mln for terminated partnershipSanofi to pay Lexicon $260 mln for terminated partnership
finance.yahoo.com - September 11 at 6:55 AM
Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?
www.fool.com - September 5 at 11:20 AM
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of "Hold" from AnalystsLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - August 31 at 4:41 AM
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Expected to Announce Quarterly Sales of $13.06 MillionLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Expected to Announce Quarterly Sales of $13.06 Million
www.americanbankingnews.com - August 29 at 1:10 AM
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Sees Significant Decline in Short InterestLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Sees Significant Decline in Short Interest
www.americanbankingnews.com - August 27 at 10:57 PM
-$0.19 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) This Quarter-$0.19 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) This Quarter
www.americanbankingnews.com - August 27 at 10:04 PM
Lexicon Pharma +4.6% as CEO buys sharesLexicon Pharma +4.6% as CEO buys shares
seekingalpha.com - August 20 at 11:42 PM
Lexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $54,000 of SharesLexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $54,000 of Shares
finance.yahoo.com - August 20 at 11:42 PM
Lexicon Pharma up 7% premarket on positive Zynquista dataLexicon Pharma up 7% premarket on positive Zynquista data
seekingalpha.com - August 10 at 8:22 AM
31 Healthcare Stocks Moving In Todays Pre-Market Session31 Healthcare Stocks Moving In Today's Pre-Market Session
feeds.benzinga.com - August 9 at 9:39 AM
Lexicon Pharmaceuticals Announces Publication of...Lexicon Pharmaceuticals Announces Publication of...
www.benzinga.com - August 9 at 8:35 AM
50 Healthcare Stocks Moving In Thursdays After-Market Session50 Healthcare Stocks Moving In Thursday's After-Market Session
feeds.benzinga.com - August 8 at 10:39 PM
28 Healthcare Stocks Moving In Todays Pre-Market Session28 Healthcare Stocks Moving In Today's Pre-Market Session
feeds.benzinga.com - August 6 at 9:10 AM
Bargain hunters move into Lexicon, up 14%Bargain hunters move into Lexicon, up 14%
seekingalpha.com - August 5 at 11:46 PM
Lexicon Pharmaceuticals Now Walking A Fine LineLexicon Pharmaceuticals Now Walking A Fine Line
seekingalpha.com - August 5 at 11:46 PM
Lexicon Is A Buy Now That All The Bad News Is OutLexicon Is A Buy Now That All The Bad News Is Out
seekingalpha.com - August 3 at 7:53 AM
Edited Transcript of LXRX earnings conference call or presentation 31-Jul-19 12:00pm GMTEdited Transcript of LXRX earnings conference call or presentation 31-Jul-19 12:00pm GMT
finance.yahoo.com - August 2 at 12:57 AM
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue EstimatesLexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
www.nasdaq.com - August 1 at 12:01 AM
Lexicon Pharmaceuticals EPS misses by $0.16, misses on revenueLexicon Pharmaceuticals EPS misses by $0.16, misses on revenue
seekingalpha.com - July 31 at 9:10 AM
Lexicon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides a Business UpdateLexicon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides a Business Update
finance.yahoo.com - July 31 at 9:10 AM
Lexicon Pharmaceuticals Announces Date Change for Second Quarter 2019 Financial Results Conference Call and Webcast to July 31, 2019Lexicon Pharmaceuticals Announces Date Change for Second Quarter 2019 Financial Results Conference Call and Webcast to July 31, 2019
feeds.benzinga.com - July 30 at 1:34 PM
Heres Why Lexicon Pharmaceuticals Is Collapsing TodayHere's Why Lexicon Pharmaceuticals Is Collapsing Today
www.fool.com - July 30 at 12:29 AM
Why Cooper Tire & Rubber, Insperity, and Lexicon Pharmaceuticals Slumped TodayWhy Cooper Tire & Rubber, Insperity, and Lexicon Pharmaceuticals Slumped Today
www.fool.com - July 29 at 4:47 PM
Lexicon Shares Fall 47% On Termination Of License Agreement With SanofiLexicon Shares Fall 47% On Termination Of License Agreement With Sanofi
www.benzinga.com - July 29 at 11:11 AM
Lexicons stock loses more than half its value after Sanofis notice to end allianceLexicon's stock loses more than half its value after Sanofi's notice to end alliance
www.marketwatch.com - July 29 at 11:11 AM
Sanofi Wants Out, Dealing Lexicons Hopes In Diabetes Another Major BlowSanofi Wants Out, Dealing Lexicon's Hopes In Diabetes Another Major Blow
seekingalpha.com - July 29 at 11:11 AM
Lexicon's stock loses more than half its value after Sanofi's notice to end allianceLexicon's stock loses more than half its value after Sanofi's notice to end alliance
finance.yahoo.com - July 29 at 11:11 AM
Lexicon Pharmaceuticals Provides Preliminary Update for Zynquista™ (Sotagliflozin) Type 2 Diabetes Phase 3 ProgramLexicon Pharmaceuticals Provides Preliminary Update for Zynquista™ (Sotagliflozin) Type 2 Diabetes Phase 3 Program
finance.yahoo.com - July 27 at 8:45 AM
Lexicon stock tanks after Sanofi ends partnershipLexicon stock tanks after Sanofi ends partnership
www.marketwatch.com - July 27 at 8:45 AM
Lexicon down 32% after hours on Sanofi exit from sotagliflozin collaborationLexicon down 32% after hours on Sanofi exit from sotagliflozin collaboration
seekingalpha.com - July 27 at 8:45 AM
Lexicon Pharmaceuticals Provides Preliminary Update for Zynquista(TM) (Sotagliflozin) Type 2 Diabetes Phase 3 ProgramLexicon Pharmaceuticals Provides Preliminary Update for Zynquista(TM) (Sotagliflozin) Type 2 Diabetes Phase 3 Program
www.marketwatch.com - July 27 at 8:45 AM
How Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Can Impact Your Portfolio VolatilityHow Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Can Impact Your Portfolio Volatility
finance.yahoo.com - July 27 at 8:45 AM
Sanofi ends partnership with Lexicon to develop add-on pill for diabetesSanofi ends partnership with Lexicon to develop add-on pill for diabetes
finance.yahoo.com - July 27 at 8:45 AM
Lexicon Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on August 1, 2019Lexicon Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on August 1, 2019
finance.yahoo.com - July 25 at 9:42 AM
Lexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseLexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 22 at 7:45 PM
Should You Be Pleased About The CEO Pay At Lexicon Pharmaceuticals, Inc.s (NASDAQ:LXRX)Should You Be Pleased About The CEO Pay At Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX)
finance.yahoo.com - June 13 at 12:53 PM
Should You Be Pleased About The CEO Pay At Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX)Should You Be Pleased About The CEO Pay At Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX)
finance.yahoo.com - June 13 at 12:53 PM
Lexicon Pharmaceuticals to Present New Clinical Data at 79th American Diabetes Association Scientific SessionsLexicon Pharmaceuticals to Present New Clinical Data at 79th American Diabetes Association Scientific Sessions
finance.yahoo.com - June 4 at 8:20 AM
Lexicon Pharmaceuticals Languishing In The Dog HouseLexicon Pharmaceuticals Languishing In The Dog House
seekingalpha.com - May 2 at 8:03 PM
Edited Transcript of LXRX earnings conference call or presentation 1-May-19 12:00pm GMTEdited Transcript of LXRX earnings conference call or presentation 1-May-19 12:00pm GMT
finance.yahoo.com - May 2 at 8:03 PM
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2019 Results - Earnings Call TranscriptLexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 7:32 PM
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Hold Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel